ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0324

Bile Acids Metabolism in Symptomatic Hand Osteoarthritis: Data from the Xiangya Osteoarthritis Study and Genetics of OA Consortium

Jiatian Li1, Jing Ye1, Tuo Yang1, david Hunter2, Weiya Zhang3, Michael Doherty3, Yuqing Zhang4, Zidan Yang1, Hui Li1, Yilun Wang1, Dongxing Xie1, Ziying Wu5, Wei Li1, Zeqin Wen1, Changjun Li1, Chao Zeng1, Guanghua Lei1 and Jie Wei1, 1Xiangya Hospital, Central South University, Changsha, Hunan, China (People's Republic), 2Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 3School of Medicine, University of Nottingham, Nottingham, United Kingdom, 4Massachusetts General Hospital, Quincy, MA, 5Xiangya Hospital, Central South University, Chang Sha, China (People's Republic)

Meeting: ACR Convergence 2025

Keywords: Epidemiology, metabolomics, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Although gut microbiome dysbiosis has been implicated in symptomatic hand OA (SHOA), the potential contribution of bile acids (BAs), key metabolites in host-microbiota interactions, to SHOA pathogenesis remains unexplored. This study examined the association between plasma BA metabolism and SHOA using data from multiple cohorts, aiming to elucidate potential pathogenic mechanisms underlying SHOA and investigate potential therapeutic targets.

Methods: Participants in the discovery cohort were drawn from the Xiangya Osteoarthritis (XO) Study, a community-based observational study. SHOA was defined as the presence of both self-reported hand symptoms and radiographic hand OA in at least one hand. Individuals without SHOA in either hand served as controls. 71 SHOA and 1,288 control participants were identified in the discovery cohort. The associations between plasma BAs and SHOA were examined using logistic regression model. We replicated the analysis to validate the association between key BAs and SHOA using a case-control design that include 71 SHOA and 71 age-, sex-, and body mass index-matched control participants, who were identified in an independent validation cohort. Multi-omics analyses were conducted to explore links between SHOA-related microbes and key BAs, while mediation analysis assessed the role of BAs in the gut microbiome-SHOA relationship. Finally, to explore the potential underlying mechanisms of the associations, we conducted gene-based meta-analyses to assess the associations between key BA receptors and SHOA using data from the XO Study and Genetics of OA Consortium.

Results: In the discovery cohort, the plasma BA profiles were primarily dominated by glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), cholic acid (CA), glycocholic acid (GCA), and deoxycholic acid (DCA) (Figure 1A). Elevated levels of deoxycholic acid (DCA) species (odds ratio [OR]=1.75, 95% confidence interval [CI]: 1.03–2.96), DCA (OR=2.14, 95% CI: 1.24–3.70), isolithocholic acid (OR=3.60, 95% CI: 1.43–9.04), and hyodeoxycholic acid (OR=2.20, 95% CI: 1.17–4.15) were positively associated with SHOA (Figure 1B-D) and its severity (Figure 1E). Similar associations between BAs and SHOA were found in the independent validation cohort (Figure 2). Multi-omics analyses revealed significant correlations between DCA species, DCA, and the DCA species/total BAs ratio with SHOA-related microbial species (Figure 3A).1 Mediation analysis showed that DCA mediated the relationships of four SHOA-related microbial species, with the mediation effects ranged from 7.0% to 24.1% (Figure 3B-E). Gene-based meta-analyses identified a significant association between the gene encoding the Farnesoid X receptor (FXR), a key BA receptor, and SHOA.

Conclusion: Dysregulated BA metabolism, particularly elevated DCA levels, is associated with SHOA and key SHOA-related microbiomes. DCA mediates the link between gut microbiota dysbiosis and SHOA, while FXR could be a treatment target for SHOA.REFERENCES1. Wei J, et al. EBioMedicine 2023;98:104892.

Supporting image 1Figure 1. Associations of plasma bile acids with symptomatic hand OA in the discovery cohort. (A) Top 15 most abundant plasma bile acid categories identified in participants with SHOA and controls. (B) Associations of bile acid species, (C) bile acid species ratios, (D) and individual plasma bile acids with SHOA, adjusting for age, sex, body mass index, smoking status, alcohol consumption, and dietary intake of meat/eggs, dairy, and vegetables. (E) Associations between key plasma bile acids and the severity of SHOA. SHOA, symptomatic hand OA; GCDCA, glycochenodeoxycholic acid; CDCA, chenodeoxycholic acid; CA, cholic acid; GCA, glycocholic acid; DCA, deoxycholic acid; GUDCA, glycoursodeoxycholic acid; GDCA, glycodeoxycholic acid; UDCA, ursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; TCA, taurocholic acid; HCA, hyocholic acid; GHCA, glycohyocholic acid; TDCA, taurodeoxycholic acid; 7-KLCA, 7-Ketolithocholic acid; DCAs, deoxycholic acid species; LCAs, lithocholic acid species; HCAs, hyocholic acid species; UDCAs, ursodeoxycholic acid species; CDCAs, chenodeoxycholic acid species; CAs, cholic acid species; BA, bile acids; KL grade, Kellgren-Lawrence grade; No of joint, number of affected joints.

Supporting image 2Figure 2. Associations of plasma bile acids with symptomatic hand OA in the Validation cohort. (A) Top 15 most abundant plasma bile acid categories identified in participants with SHOA and controls. (B) Bile acid species validated in the validation cohort. (C) Bile acid species ratios validated in the validation cohort. (D) Individual plasma bile acid validated in the validation cohort. (E) Associations between key plasma bile acids and the severity of SHOA. SHOA, symptomatic hand OA; GCDCA, glycochenodeoxycholic acid; CDCA, chenodeoxycholic acid; GCA, glycocholic acid; CA, cholic acid; DCA, deoxycholic acid; GDCA, glycodeoxycholic acid; GUDCA, glycoursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; UDCA, ursodeoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; HCA, hyocholic acid; GHDCA, glycohyodeoxycholic acid; 7-KLCA, 7-ketolithocholic acid; DCAs, deoxycholic acid species; KL grade, Kellgren-Lawrence grade; No of joint, number of affected joints.

Supporting image 3Figure 3. Correlations between gut microbial species to plasma bile acids in symptomatic hand OA. (A) Correlations between SHOA-related plasma bile acids and SHOA-related microbiome species. The correlations were calculated by partial Spearman’s rank correlation test. (B) Mediation effect of DCA on the association between Bilophila wadsworthia and SHOA. (C) Mediation effect of DCA on the association between Bacteroides A mediterraneensis and SHOA. (D) Mediation effect of DCA on the association between Haemophilus D parainfluenzae L and SHOA. (E) Mediation effect of DCA on the association between Haemophilus D parainfluenzae N and SHOA.The proportions of the indirect effect (mediation effect) are labeled at the center of the ring charts. SHOA, symptomatic hand OA; DCA, deoxycholic acid.


Disclosures: J. Li: None; J. Ye: None; T. Yang: None; d. Hunter: None; W. Zhang: None; M. Doherty: None; Y. Zhang: None; Z. Yang: None; H. Li: None; Y. Wang: None; D. Xie: None; Z. Wu: None; W. Li: None; Z. Wen: None; C. Li: None; C. Zeng: None; G. Lei: None; J. Wei: None.

To cite this abstract in AMA style:

Li J, Ye J, Yang T, Hunter d, Zhang W, Doherty M, Zhang Y, Yang Z, Li H, Wang Y, Xie D, Wu Z, Li W, Wen Z, Li C, Zeng C, Lei G, Wei J. Bile Acids Metabolism in Symptomatic Hand Osteoarthritis: Data from the Xiangya Osteoarthritis Study and Genetics of OA Consortium [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/bile-acids-metabolism-in-symptomatic-hand-osteoarthritis-data-from-the-xiangya-osteoarthritis-study-and-genetics-of-oa-consortium/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bile-acids-metabolism-in-symptomatic-hand-osteoarthritis-data-from-the-xiangya-osteoarthritis-study-and-genetics-of-oa-consortium/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology